• Online Features  This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (35)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Cardiovascular System  • Quality of Care  • Evidence-Based Medicine  • Women's Health  • Women's Health, Other  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Sanket S. Dhruva, BA; Rita F. Redberg, MD, MSc

Arch Intern Med. 2008;168(2):136-140.

Background  There is a paucity of data on the adequacy of the resources and tools used by the Centers for Medicaid and Medicare Services (CMS) in making national coverage determinations about services for beneficiaries. The objective of this study was to determine the extent to which clinical trials relied on by the CMS are applicable to Medicare beneficiaries.

Methods  We performed a meta-analysis of data on 40 009 individuals from all 141 trials included in the technology assessments for the 6 cardiovascular disease meetings of the CMS advisory panel and compared them with the demographics of the Medicare population.

Results  Medicare beneficiaries differ significantly from the cardiovascular clinical trial participants used to inform Medicare coverage decisions. Clinical trial participants, compared with beneficiaries, are more likely to be younger (60.1 vs 74.7 years), male (75.4% vs 41.8%), and non-US residents (60% vs 0%). The clinical trials, moreover, rarely included outcome stratification by age, sex, and race.

Conclusions  Participants in cardiovascular studies relied on by the CMS for coverage determinations differ substantially from the Medicare population. Data frequently are not available on relevant subgroup populations. Suggestions are made that address the need for data more relevant to Medicare beneficiaries by increasing enrollment of, and reporting on, women and elderly individuals in clinical trials and use of relevant data for coverage decisions.

Author Affiliations: Division of Cardiology, Department of Medicine, and Women's Cardiovascular Services (Dr Redberg), University of California at San Francisco School of Medicine (Mr Dhruva).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Generalizability of the Results of Randomized Trials
Noel S. Weiss, Thomas D. Koepsell, and Bruce M. Psaty
Arch Intern Med. 2008;168(2):133-135.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey
Le Strat et al.
Tobacco Control 2011;20:338-343.
ABSTRACT | FULL TEXT  

Do Postmarketing Surveillance Studies Represent Real-World Populations?: A Comparison of Patient Characteristics and Outcomes After Carotid Artery Stenting
Yeh et al.
Circulation 2011;123:1384-1390.
ABSTRACT | FULL TEXT  

Age-Based Exclusions From Cardiovascular Clinical Trials: Implications for Elderly Individuals (and for All of Us): Comment on "The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure"
Gurwitz and Goldberg
Arch Intern Med 2011;171:557-558.
FULL TEXT  

Clinical Trial Enrollment and Progress in Women's Health
Dhruva and Redberg
JAMA 2011;305:1197-1197.
FULL TEXT  

Best Clinical Practice: Art, Science, or Both?: Comment on "Implantable Cardiac Device Procedures in Older Patients"
Kusumoto
Arch Intern Med 2010;170:638-639.
FULL TEXT  

Cardiovascular Imaging Research at the Crossroads
Shaw et al.
J Am Coll Cardiol Img 2010;3:316-324.
ABSTRACT | FULL TEXT  

Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention
Melloni et al.
Circ Cardiovasc Qual Outcomes 2010;3:135-142.
ABSTRACT | FULL TEXT  

Are Implanted Defibrillators Effective Therapy in the Elderly?: Asked, Not Answered
Havranek and Peterson
Circ Heart Fail 2010;3:4-6.
FULL TEXT  

Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure
Hernandez et al.
Circ Heart Fail 2010;3:7-13.
ABSTRACT | FULL TEXT  

Women's Cardiovascular Health: Prevention Is Key
Oertelt-Prigione and Regitz-Zagrosek
Arch Intern Med 2009;169:1740-1741.
FULL TEXT  

ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research
Redberg et al.
J Am Coll Cardiol 2009;54:1364-1405.
FULL TEXT  

AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association
WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:1296-1336.
FULL TEXT  

Is What Is Good for the Gander Really Good for the Goose?
Redberg
Arch Intern Med 2009;169:1460-1461.
FULL TEXT  

Outcomes Associated With Tiotropium Use in Patients With Chronic Obstructive Pulmonary Disease
Lee et al.
Arch Intern Med 2009;169:1403-1410.
ABSTRACT | FULL TEXT  

Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease
Lee et al.
ANN INTERN MED 2008;149:380-390.
ABSTRACT | FULL TEXT  

Should we use large scale healthcare interventions without clear evidence that benefits outweigh costs and harms? No
Landefeld et al.
BMJ 2008;336:1277-1277.
FULL TEXT  

Generalizability of the Results of Randomized Trials
Weiss et al.
Arch Intern Med 2008;168:133-135.
FULL TEXT